Clinical Trial Results TV
Duke Clinical Medicine: 235 submissions (showing 136 to 150)

| Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 |

1 Star 2 Star 3 Star 4 Star 5 Star
Carotid Stenting and Beyond
Dr. Jay S. Yadav, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Percutaneous Balloon Valvuloplasty
Dr. Howard Herrmann, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Direct Thrombin Inhibition in PCI
Dr. A. Michael Lincoff, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Magnetic Assisted Intervention: A first foray into cath lab robotics
Dr. Neal Kleiman, MD

1 Star 2 Star 3 Star 4 Star 5 Star
How to Manage Drug Eluting Stent In-Stent Restenosis
Dr. Ron Waksman, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Vascular Inflammation: Pathobiology and Serum Markers of ACS
Dr. Dean J. Kereiakes, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Reduction of Infarct Size After Primary PCI
Dr. William O'Neill, MD

1 Star 2 Star 3 Star 4 Star 5 Star
X-Ray Contrast Agents: What Interventional Cardiologists Need to Know
Dr. John W. Hirshfeld, Jr., MD

1 Star 2 Star 3 Star 4 Star 5 Star
Multivessel Therapy in Diabetic Patients in the Drug Eluting Stent Era
Dr. Spencer King, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Preventing Myocardial Infarctions Using Prophylactic DES
Dr. Richard Kuntz, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Cardiogenic Shock
Dr. Eric Bates, MD

1 Star 2 Star 3 Star 4 Star 5 Star
The Truth About Drug Eluting Stents: Clinical Restenosis, Stent Thrombosis, and Long-Term Anti-Ischemic Therapy after PC
Dr. Jeffrey Popma, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Cardiac Complications of Percutaneous Coronary Intervention
Dr. John Douglas, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Contrast Nephropathy
Dr. Peter McCullough, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Vascular Inflammation in Acute Coronary Syndromes and PCI: Modulation by Adjunctive Pharmacotherapy
Dr. Dean J. Kereiakes, MD